Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
LAS VEGAS –
Almost half of patients with cancer did not use anything to manage related symptoms, according to an ASCO poll.
The agency is collaborating with the Bill & Melinda Gates Foundation for the $200 million, 4-year project.
News from the FDA/CDC
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
Dr. Douglas S. Paauw describes the best approach to anticoagulation in patients with atrial fibrillation who are on anticoagulation, then have a...
Survivors of childhood non-Hodgkin may be at significantly increased risk for breast, ovarian, prostate, and other BRCA2-associated cancers.
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.